Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis

Abstract

Tumor necrosis factor- inhibitors may induce various cutaneous side effects including eczematous-like lesions. The management of such side effects can be challenging. Herein, we report a case of a 55-year-old man who had a flare-up and subsequent improvement of atopic dermatitis during treatment of severe psoriasis with adalimumab. © 2013 S. Karger AG, Basel.